Solid Biosciences (SLDB) Operating Expenses (2017 - 2026)
Solid Biosciences (SLDB) posted Operating Expenses of $57.3 million for Q1 2026, up 16.0% sequentially from $49.4 million in Q4 2025, and up 43.08% YoY from $40.1 million in Q1 2025.
Solid Biosciences (SLDB) Operating Expenses (2017 - 2026) Analysis & Trends
Solid Biosciences has reported Operating Expenses for 10 years, with the latest figure at $57.3 million in Q1 2026.
- Quarterly Operating Expenses rose 43.08% year-over-year to $57.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $196.5 million (up 37.46% YoY) and the FY2025 annual result came in at $179.2 million, up 38.14% from the prior year.
- Operating Expenses rose to $57.3 million in Q1 2026 per SLDB's latest filing, from $49.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $57.3 million in Q1 2026 and troughed at $21.1 million in Q3 2022.
- A 5-year average of $34.4 million and a median of $32.0 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 35.59% in 2023, then soared 79.19% in 2024.
- Over 5 years, Operating Expenses stood at $34.6 million in 2022, then sank by 35.59% to $22.3 million in 2023, then jumped by 79.19% to $39.9 million in 2024, then climbed by 23.83% to $49.4 million in 2025, then advanced by 16.0% to $57.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $57.3 million, $49.4 million, and $48.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Solid Biosciences | 1.32 Bn | 1.32 Bn | - | 57.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.38 Mn |
| Mar 31, 2026 | 57.31 Mn |
| Dec 31, 2025 | 49.40 Mn |
| Sep 30, 2025 | 48.06 Mn |
| Jun 30, 2025 | 41.69 Mn |
| Mar 31, 2025 | 40.05 Mn |
| Dec 31, 2024 | 39.90 Mn |
| Sep 30, 2024 | 35.18 Mn |
| Jun 30, 2024 | 27.79 Mn |
| Mar 31, 2024 | 26.86 Mn |
| Dec 31, 2023 | 22.27 Mn |
| Sep 30, 2023 | 23.11 Mn |
| Jun 30, 2023 | 26.84 Mn |
| Mar 31, 2023 | 32.03 Mn |
| Dec 31, 2022 | 34.57 Mn |
| Sep 30, 2022 | 21.13 Mn |
| Jun 30, 2022 | 31.55 Mn |
| Mar 31, 2022 | 27.30 Mn |
| Dec 31, 2021 | 21.81 Mn |
| Sep 30, 2021 | 21.57 Mn |